Brayden Cabral has been in remission for some time but he serves as inspirations for others who have gone or will go through a similar experience.

Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial ...

A native of Southern California and a Crespi Carmelite High School graduate, Kyle Owens received his devastating leukemia ...

Panelists discuss how the greatest unmet needs include addressing poor outcomes in specific subsets like TP53-mutant disease, ...

Privately-held cell therapy company Orca Bio has announced that the US Food and Drug Administration (FDA) has accepted for ...

At 14, Matt Baar received a dream from the Children's Dream Fund. At 27, he wants to grant dreams in Manatee County.

Honor Presented at the 19th Annual Invest in Others Awards Gala in Boston, Raising $1 Million for Blood Cancer United and ...

Five-Year-Old Leukemia Survivor Meets Marrow Donor at “Battle of the Badges” EventBOCA RATON, Fla., Oct. 07, 2025 (GLOBE ...

Kronos was bought out earlier this year for a knockdown price of around $35 million by serial biotech acquisition specialist ...

Archie Lyndhurst was an English actor and designer who gained notoriety through his portrayal of Oliver Coulton, called Ollie, in the CBBC comedy series So Awkward.

FDA has issued a Complete Response Letter (CRL) regarding Xspray Pharma's New Drug Application (NDA) for Dasynoc, referring to GMP (Good Manufacturing Practice) observations at a contract manufacturer ...